ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "mental health"

  • Abstract Number: 1231 • ACR Convergence 2023

    Successful Implementation of a Mental Health Screening Program for Youth with Juvenile Dermatomyositis

    Y. Ingrid Goh1, Kayla Baker1, Audrey Bell-Peter1, Vanessa Carbone1, Brian Feldman1, Luana Flores Pereira1, Jayne MacMahon1, Valerio Maniscalco1, Jo-Anne Marcuz1, Greta Mastrangelo2, Tanya Slater1, Kristi Whitney1 and Andrea Knight1, 1The Hospital for Sick Children, Toronto, ON, Canada, 2Division of Rheumatology, Department of Paediatrics, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada

    Background/Purpose: High levels of emotional distress have been reported in children with juvenile myositis (JM). Inadequate recognition of mental health concerns by healthcare providers (HCPs)…
  • Abstract Number: 2485 • ACR Convergence 2023

    Comparative Risk of Serious Psychiatric Events with Belimumab versus Oral Immunosuppressant Use in Patients with Systemic Lupus Erythematosus

    April Jorge1, Baijun Zhou1, Yuqing Zhang2 and Hyon K. Choi3, 1Massachusetts General Hospital, Boston, MA, 2Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital, Boston, MA, 3Massachusetts General Hospital and Harvard Medical School, Lexington, MA

    Background/Purpose: In randomized placebo-controlled trials, including the phase 4 Belimumab Assessment of Safety in SLE study, belimumab use was associated with a higher incidence of…
  • Abstract Number: 1237 • ACR Convergence 2023

    The Associations Between Depressive Symptoms and Executive Function and Academic Outcomes in Children with SLE

    Hannah Bradfield1, Paola Sparagana2, Elizabeth Sloan1, Chanhee Jo3, Tracey Wright1 and Sheryl Frierson2, 1UT Southwestern, Dallas, TX, 2Scottish Rite for Children, Dallas, TX, 3Texas Scottish Rite Hospital, Dallas, TX

    Background/Purpose: Children with juvenile-onset SLE (jSLE) have high rates of depression.1-2 Adolescents with depression, but without a chronic illness, have lower academic engagement, efficacy, and…
  • Abstract Number: 2500 • ACR Convergence 2023

    Suicidal Ideation and Self-Efficacy in Systemic Lupus Erythematosus: Georgians Organized Against Lupus (GOAL) Cohort

    Charmayne Dunlop-Thomas1, Gaobin Bao1, Jessica Williams2, Hilton Mozee1, Cristina Drenkard1 and S. Sam Lim1, 1Emory University, Atlanta, GA, 2Emory University School of Medicine, Atlanta, GA

    Background/Purpose: Suicidal ideation is more common in SLE than in other chronic diseases. Targeted interventions are needed to reduce morbidity and mortality. Bandura’s theory of…
  • Abstract Number: 1241 • ACR Convergence 2023

    Adverse Childhood Experiences in a Paediatric Systemic Lupus Erythematosus Cohort

    Stephanie Fevrier1, Olivia Hendrikx1, Ashley Danguecan1, Asha Jeyanathan1, Lawrence Ng1, Ibrahim Mohamed2, Paris Moaf1, Sondos Ayyash1, Chelsea DeCoste3, Deborah Levy1, Linda Hiraki1 and Andrea Knight1, 1The Hospital for Sick Children, Toronto, ON, Canada, 2The Hospital for Sick Children, Brampton, ON, Canada, 3IWK Health Centre, Halifax, NS, Canada

    Background/Purpose: Systemic lupus erythematosus (SLE) is a chronic, multiorgan autoimmune disease in which 20% of cases are diagnosed in childhood. Adverse childhood experiences (ACEs) are…
  • Abstract Number: PP03 • ACR Convergence 2023

    Lupus with Slime: Improve QOL and Increase ROM in SLE with Slime

    Amanda Greene, Los Angeles, CA

    Background/Purpose: In 1983, over forty years ago, I was diagnosed with Systemic Lupus Erythematosus (SLE).  I was immediately prescribed high dose corticosteroids.  My body and…
  • Abstract Number: 1249 • ACR Convergence 2023

    Cross-Sectional Associations of Emotional Distress and Cardiovascular Health in Juvenile Lupus and Dermatomyositis

    Kaveh Ardalan1, Angel Davalos1, Hwanhee Hong1, Bryce Reeve1, Christoph Hornik1, M. Anthony Moody1, Donald Lloyd-Jones2, Eveline Wu3, Audrey Ward1, Rebecca Sadun4, Jeffrey Dvergsten5, Ann Reed6, Mark Connelly7 and Laura Schanberg1, 1Duke University School of Medicine, Durham, NC, 2Northwestern University Feinberg School of Medicine, Chicago, IL, 3University of North Carolina School of Medicine, Chapel Hill, NC, 4Duke University, Durham, NC, 5Duke University School of Medicine, Hillsborough, NC, 6Duke University School of Medicine, Chapel HIll, NC, 7Children's Mercy Kansas City / University of Missouri-Kansas City School of Medicine, Kansas City, MO

    Background/Purpose: Juvenile lupus (JSLE) and dermatomyositis (JDM) patients are at high risk for cardiovascular disease (CVD). The American Heart Association cardiovascular health (CVH) construct is…
  • Abstract Number: 1259 • ACR Convergence 2023

    Voices Unheard: Unmasking the Hidden Challenges of Youth with Rheumatic Diseases

    Natasha Trehan1, Laurie Proulx2 and Isabel Dukes3, 1University of Ottawa, Take a Pain Check Foundation, Toronto, ON, Canada, 2Canadian Arthritis Patient Alliance, Ottawa, ON, Canada, 3CAPA & TAPC, Freelance, Ottawa, ON, Canada

    Background/Purpose: Rheumatic disease doesn't merely present physical challenges—it also significantly impacts various psychological and social aspects of one's life, often disrupting academic progress, straining friendships,…
  • Abstract Number: 1261 • ACR Convergence 2023

    Network Analysis of Depression and Anxiety Symptoms in Chinese Rheumatoid Arthritis Patients

    Zhang Lijuan and Wu Beiwen, Shanghai Jiao Tong University School of Medicine, Shanghai, China

    Background/Purpose: Rheumatoid arthritis (RA) patients are susceptible to comorbid anxiety and depression. From the network model perspective, comorbidity is due to direct interactions between depression…
  • Abstract Number: 1301 • ACR Convergence 2023

    The Relationship Between Socioeconomic Factors and Persistent Active Rheumatoid Arthritis: Results from (NEIAA) a Large UK Cohort of Early Inflammatory Arthritis

    Maryam Adas1, Sam Norton1, Andrew Cope1, Maya Buch2, James Galloway1 and Elena Nikiphorou1, 1King's College London, London, United Kingdom, 2University of Manchester and NIHR Manchester Biomedical Research Centre, Manchester, United Kingdom

    Background/Purpose: Psychosocial factors may interplay with biological factors to drive a refractory disease state in patients with inflammatory arthritis1. We aim to explore which socioeconomic,…
  • Abstract Number: 112 • 2023 Pediatric Rheumatology Symposium

    Adverse Childhood Experiences: Prevalence and Relationship to Disease in Childhood-onset Lupus

    Olivia Hendrikx1, Stephanie Fevrier1, Ibrahim Mohamed1, Chelsea DeCoste2, Paris Moaf1, Lawrence Ng1, Deborah Levy1, Linda Hiraki1, Alene Toulany1 and Andrea Knight1, 1The Hospital for Sick Children, Toronto, ON, Canada, 2IWK Health Centre, Halifax, NS, Canada

    Background/Purpose: Adverse Childhood Experiences (ACEs) measure traumatic experiences in childhood. ACEs are associated with epigenetic changes, are known to increase stress response and inflammation, and…
  • Abstract Number: 006 • 2023 Pediatric Rheumatology Symposium

    Implementation of Automated Depression Screening in Patients with Lupus in a Tertiary Pediatric Rheumatology Clinic

    Lauren Harper1, Alana Goldstein-Leever1, James Gallup1, Vidya Sivaraman2, Stacy Ardoin1, Kyla Driest1, Evan Mulvhihill3 and Alysha Taxter4, 1Nationwide Children's Hospital, Columbus, OH, 2Nationwide Children's Hospital/ The Ohio State University, Columbus, OH, 3Nemours Children's Hospital, 4Nationwide Children's Hospital, Columbus, OH

    Background/Purpose: Patients with chronic rheumatic conditions, particularly lupus, have higher rates of depression, which significantly impacts their lives and can lead to poor medication compliance…
  • Abstract Number: 010 • 2023 Pediatric Rheumatology Symposium

    Remotely Delivered Psychological Intervention May Be Beneficial to Youth with Childhood-Onset Lupus: A Preliminary Investigation

    Natoshia Cunningham1, Michelle Adler2, Ashley Danguecan3, Mallet Reid2, Samantha Ely4, Mathew Reeves2, Lawrence Ng3, Paris Moaf3, Sarah Mossad3, Tala El Tal3, Luana Flores Pereira3, Deborah Levy3, Linda Hiraki3, Jennifer Stinson3, Sarah Ahola Kohut3, Khalid Abulaban5, Elizabeth Kessler5, Stacy Allen5, Tamar Rubinstein6, Evin Rothschild6, Natalie Rosenwasser7, Kabita Nanda7, Susan Canny7, Emily Smitherman8, Livie Huie8, James Birmingham9, Allison Thompson10, Janel Thompson10, Miranda Moyer10, Emily Nguyen10, Angela Chapson10 and Andrea Knight3, 1Michigan State University, Grand Rapids, MI, 2Michigan State University, East Lansing, 3The Hospital for Sick Children, Toronto, ON, Canada, 4Wayne State University, Michigan State University, Detroit, MI, 5Helen DeVos Children's Hospital, Grand Rapids, MI, 6Children's Hospital at Montefiore, New York, NY, 7Seattle Children's Hospital, Seattle, WA, 8University of Alabama at Birmingham, Birmingham, AL, 9Metro Health, Cleveland, 10Patient Co-Investigative Team

    Background/Purpose: Childhood-onset systemic lupus erythematosus (cSLE) is associated with fatigue, pain, and depressive symptoms that adversely impact health-related quality of life. The Treatment and Education…
  • Abstract Number: 022 • 2023 Pediatric Rheumatology Symposium

    Narrative Medicine and Pediatric Rheumatology: Addressing Burnout and Bias

    aviya lanis, Natalie Rosenwasser and Esi Morgan, Seattle Children's Hospital, Seattle, WA

    Background/Purpose: Burnout, a syndrome of emotional exhaustion and depersonalization, adversely impacts healthcare. This can result in mood disturbances, poor patient and provider satisfaction and high…
  • Abstract Number: 049 • 2023 Pediatric Rheumatology Symposium

    What Happens After Juvenile Myositis Patients Screen Positive for Mental Health Comorbidities? Update from a Multicenter Juvenile Myositis Mental Health Screening Pilot Study

    Kaveh Ardalan1, Rebecca Fillipo1, Christina ZIgler2, Audrey Ward1, Jeffrey Dvergsten3, Ann Reed1, Alison Manning1, Gary Maslow1, Brian Feldman4, Ashley Danguecan5, Sarah Mossad5, Luana Flores Pereira5, Susan Shenoi6, Stacey Haynes7, Joanna Patten7 and Andrea Knight5, 1Duke University School of Medicine, Durham, NC, 2Duke, Durham, NC, 3Duke University Hospital, Durham, NC, 4Hospital for Sick Children / University of Toronto, Toronto, ON, Canada, 5The Hospital for Sick Children, Toronto, ON, Canada, 6Seattle Children's Hospital, Seattle, WA, 7Seattle Childrens Hospital and Research Center / University of Washington, Seattle, WA

    Background/Purpose: Juvenile myositis (JM) patients report high rates of emotional distress but qualitative studies suggest challenges accessing high quality mental health care. We present survey…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 8
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology